Literature DB >> 3756669

The cytology, histology and prevalence of cell types in canine lymphoma classified according to the National Cancer Institute Working Formulation.

R F Carter, V E Valli, J H Lumsden.   

Abstract

No significance has been shown yet between the cytological subtypes of canine lymphoma and clinical behaviour. This paper describes and illustrates the cytological and histological criteria for application of the National Cancer Institute Working Formulation classification system, a scheme with demonstrated prognostic capability for human non-Hodgkin's lymphomas, to a series of 285 canine lymphomas. The Working Formulation can be used without difficulty for canine lymphomas. Low grade follicular tumors were found to be much less common, and high grade, aggressive tumors much more common than these cell types in humans. Low grade tumors tend to have low mitotic rates and high grade tumors tend to have high mitotic rates. There may be an association between hypercalcemia and lymphoblastic cell type. A review of available literature data for canine lymphomas suggests that prognostic extrapolation of clinical behaviour based on human lymphoma data may be possible. These results suggest that there may be strong similarities of morphology and behaviour between human non-Hodgkin's lymphomas and canine lymphomas.

Entities:  

Mesh:

Year:  1986        PMID: 3756669      PMCID: PMC1255183     

Source DB:  PubMed          Journal:  Can J Vet Res        ISSN: 0830-9000            Impact factor:   1.310


  20 in total

1.  War of the words: classification of non-Hodgkin's lymphomas.

Authors:  D H Moir
Journal:  Pathology       Date:  1983-10       Impact factor: 5.306

2.  A clinicopathologic study in advanced non-Hodgkin's lymphomas treated with sequential non-cross-resistant regimens: comparison of the working formulation with the Rappaport and Kiel classifications.

Authors:  S Monfardini; F Rilke; P Valagussa; E Bajetta; R Canetta; R Buzzoni; R Giardini; S Viviani
Journal:  Eur J Cancer Clin Oncol       Date:  1984-05

3.  Malignant lymphomas.

Authors:  B H Tindle
Journal:  Am J Pathol       Date:  1984-07       Impact factor: 4.307

Review 4.  Current status and perspectives in the treatment of non-Hodgkin's lymphomas.

Authors:  H P Honegger; F Cavalli
Journal:  Eur J Cancer Clin Oncol       Date:  1984-03

5.  Doxorubicin for treatment of canine lymphosarcoma after development of resistance to combination chemotherapy.

Authors:  C A Calvert; C E Leifer
Journal:  J Am Vet Med Assoc       Date:  1981-11-15       Impact factor: 1.936

6.  Histocytology of lymphoid tumors in the dog, cat and cow.

Authors:  V E Valli; B J McSherry; B M Dunham; R M Jacobs; J H Lumsden
Journal:  Vet Pathol       Date:  1981-07       Impact factor: 2.221

7.  Histologic classification as an indication of therapeutic response in malignant lymphoma of dogs.

Authors:  K N Gray; G L Raulston; C A Gleiser; J H Jardine
Journal:  J Am Vet Med Assoc       Date:  1984-04-01       Impact factor: 1.936

8.  Phenotyping of canine lymphoma with monoclonal antibodies directed at cell surface antigens: classification, morphology, clinical presentation and response to chemotherapy.

Authors:  F R Appelbaum; G E Sale; R Storb; K Charrier; H J Deeg; T Graham; J C Wulff
Journal:  Hematol Oncol       Date:  1984 Apr-Jun       Impact factor: 5.271

9.  Hypercalcemia in dogs with lymphosarcoma. Biochemical, ultrastructural, and histomorphometric investigations.

Authors:  D J Meuten; G J Kociba; C C Capen; D J Chew; G V Segre; L Levine; A H Tashjian; E F Voelkel; L A Nagode
Journal:  Lab Invest       Date:  1983-11       Impact factor: 5.662

10.  Histologic classification as a prognostic criterion for canine lymphosarcoma.

Authors:  R E Weller; C A Holmberg; G H Theilen; B R Madewell
Journal:  Am J Vet Res       Date:  1980-08       Impact factor: 1.156

View more
  7 in total

1.  Multiple mucocutaneous lymphosarcoma in a dog.

Authors:  J M da Silva Curiel; D L McCaw; M A Turk; D A Schmidt
Journal:  Can Vet J       Date:  1988-12       Impact factor: 1.008

2.  Canine lymphoma-associated antigens defined by murine monoclonal antibodies.

Authors:  Z Steplewski; K A Jeglum; C Rosales; N Weintraub
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

Review 3.  Fetal Microchimerism in Cancer Protection and Promotion: Current Understanding in Dogs and the Implications for Human Health.

Authors:  Jeffrey N Bryan
Journal:  AAPS J       Date:  2015-02-19       Impact factor: 4.009

4.  A comparison between the cytological and histological characteristics in thirteen canine and feline thymomas.

Authors:  C A Rae; R M Jacobs; C G Couto
Journal:  Can Vet J       Date:  1989-06       Impact factor: 1.008

5.  Canine cutaneous epitheliotropic lymphoma (mycosis fungoides) is a proliferative disorder of CD8+ T cells.

Authors:  P F Moore; T Olivry; D Naydan
Journal:  Am J Pathol       Date:  1994-02       Impact factor: 4.307

6.  Gallbladder lymphoma in a miniature dachshund.

Authors:  Nao Nagata; Sanae Shibata; Hiroki Sakai; Hiroaki Konno; Satoshi Takashima; Mifumi Kawabe; Takashi Mori; Hitoshi Kitagawa; Makoto Washizu
Journal:  J Vet Med Sci       Date:  2014-10-10       Impact factor: 1.267

7.  Tumor microvessel density-associated mast cells in canine nodal lymphoma.

Authors:  Moges Woldemeskel; Elizabeth Mann; Lisa Whittington
Journal:  SAGE Open Med       Date:  2014-11-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.